Member Login

 
Forgot password/Login issues?
Not a Member? Learn more.
  • Blog
  • Partnership
  • Contact
  • Cart (0)
  • Member Login
BCC Research
BCC Research
  • Member Login
  • Solution
    • Membership Membership
      • Academic
      • Corporate
    • Market Research
    • Custom Research
    • Company Index
    • Scorecard
  • Industries Industries
    • Life Sciences Life Sciences
      • Med Devices & Surgical
      • Cell Biology
      • Pharmaceuticals
      • Health Maintenance
    • Digital World Digital World
      • Instrumentation & Sensors
      • Safety and Security
      • Engineering
      • Photonics
      • Information Technology
    • Materials Materials
      • Advanced Materials
      • Plastics
      • Chemicals
      • Semiconductor
      • Nanotechnology
    • Energy & Sustainability Energy & Sustainability
      • Water-Membrane and Separations
      • Fuel Cell and Battery
      • Food
      • Energy
      • Manufacturing
      • Environment
  • Resources Resources
    • Blog
    • e-Course
    • Spotlights Library
    • Megatrends
    • Association Exclusives
    • Partnership
    • Market Research Studies
  • About
    • About BCC Research
    • Press Releases
    • Events
    • Careers
    • Contact
  • Beacon SearchBeacon Search

Or Ask your question to the BCC Research BEACON Beacon Research

  1. Company Index
  2. Natera Inc.
  3. News

Natera Inc.

  • Overview
  • Financial
  • In Reports
  • Products
  • News

In News

Natera's 'Signatera' detects recurrence of cancer through a blood test - Fox Business

Fox Business - Jul 08, 2025

Natera Presents Data at ESMO GI on its Tissue-Free Latitude™ MRD* Assay, Demonstrating Excellent Overall Performance in Colorectal Cancer - BioSpace

BioSpace - Jul 08, 2025

Natera Rings the Opening Bell - Nasdaq

Nasdaq - Jul 08, 2025

Should You Invest in Natera (NTRA)? - Insider Monkey

Insider Monkey - Jul 04, 2025

Natera Inks $8.25M Deal To End Faulty Prenatal Tests Suit - Law360

Law360 - Jul 03, 2025

Natera Presents Data at ESMO GI on its Tissue-Free Latitude™ MRD* Assay, Demonstrating Excellent Overall Performance in Colorectal Cancer - New Castle News

New Castle News - Jul 07, 2025

Natera's Tissue-Free Latitude™ MRD Assay: A Precision Oncology Breakthrough with Near-Term Catalysts - AInvest

AInvest - Jul 08, 2025

Natera: Growth Likely To Moderate, Despite Signatera Test Medicare Coverage (NASDAQ:NTRA) - Seeking Alpha

Seeking Alpha - Jun 17, 2025

Natera to Present Clinical and Economic Utility of Signatera at ESMO GI, Highlights Innovations in MRD - Yahoo Finance

Yahoo Finance - Jul 01, 2025

CareDx gets $96 million jury win for Natera overturned - Reuters

Reuters - Feb 24, 2025

Natera Inc. Reports Strong Q1 2025 Financial Growth - TipRanks

TipRanks - May 09, 2025

Natera Announces Medicare Coverage for Signatera ™ Genome - Business Wire

Business Wire - Jun 04, 2025

BCC Research Beacon
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Thank you for your interest in BCC Research. You will be added to our mailing list.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

Contact
  • 781-489-7301
  • info@bccresearch.com

© 2025 BCC Research

Privacy Policy |Site Map|Terms & Conditions

Please select categories of interest:

Check All